Rigel Pharmaceuticals Inc. (New)

AED108.3
AED
Last updated on --.
24h volume296.09K
24h highest113.43 AED
24h lowest106.43 AED
24h Price movement+1.10%

RIGL recent prices

24 Hours
+1.10%+AED1.175
30 days
-3.22%-AED3.611
60 days
+15.00%+AED14.16
90 days
-14.86%-AED18.97

Key data

Previous close107.13 AED
Market cap1.96B AED
Volume296.09K
P/E ratio1.460000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)72.3155 AED
Net income (FY)1.34B AED
Revenue (FY)1.10B AED
Last report dateMay 5, 2026

About Rigel Pharmaceuticals Inc. (New)

PHARMACEUTICAL PREPARATIONS
HeadquartersSOUTH SAN FRANCISCO
Employees (FY)174.00
Revenue per employee (FY)6.33M AED
Net income per employee (FY)7.69M AED
Listed onNasdaq
Official website

RIGL conversion tables

RIGLRIGL
AEDAED
0.5 RIGL54.15 AED
1 RIGL108.3 AED
5 RIGL541.53 AED
10 RIGL1,083.07 AED
AEDAED
RIGLRIGL
0.5 AED0.0046165 RIGL
1 AED0.0092329 RIGL
5 AED0.046165 RIGL
10 AED0.092329 RIGL

FAQ

RIGL is trading at AED108.30, +1.10% over the last 24 hours. Track live moves on the price chart at the top of this page.
The RIGL stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. RIGL is currently trading at AED108.30, +1.10% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on RIGL price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. RIGL's P/E ratio is currently 1.460000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from RIGL; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against RIGL's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Rigel Pharmaceuticals Inc. (New)'s market cap is currently 1.96B AED. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume296.09K
24h highest113.43 AED
24h lowest106.43 AED
24h Price movement+1.10%
RIGLRIGL
AEDAED
Start trade with RIGL Perpetual